ClickHouse leverages agentic analytics internally with LibreChat-and-ClickHouse-powered DWAINE (Data Warehouse AI Natural ...
QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...
Gliomas are the most prevalent and aggressive primary brain tumors, characterized by profound tumor heterogeneity, poor prognosis, and limited therapeutic ...
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...
You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England partners with the NHS to provide whole genome ...
Therapeutics Startup Helex Secures USD 3.5 Mn to Develop Targeted Kidney Treatments Helex, a therapeutics startup focused on genetic kidney diseases, has raised USD 3.5 million in a seed funding round ...
Bluehill Capital, SOSV, and other global investors participated in the round. The Hyderabad- and US-based biotech startup ...
Research institutes are projected to capture 50% of total market revenue in 2025, reflecting their pivotal role in genomic innovation. These institutions rely heavily on high-throughput sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback